Results 111 to 120 of about 364,170 (283)

Hepatitis B Vaccine Use in Health Care Professionals [PDF]

, 1982
Edward Septimus
openalex   +1 more source

A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report [PDF]

, 1981
W. Szmuness, Cladd E. Stevens, Edith Zang, Edward J. Harley, Aaron Kellner   +4 more
openalex   +1 more source

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing

Small, EarlyView.
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa, Mamata Karmacharya, Hyunmin Choi, Sumit Kumar, Yoon‐Kyoung Cho   +4 more
wiley   +1 more source

Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration

Revista do Instituto de Medicina Tropical de São Paulo, 2001
A significantly diminished antibody response to hepatitis B vaccine has been demonstrated in adults when the buttock is used as the injection site.
Andrea Santos Rafael ALVES, Cristiane M.R. NASCIMENTO, Celso H. GRANATO, Helena Keiko SATO, Marina F. MORGATO, Claudio S. PANNUTI   +5 more
doaj  

Exosome‐Based Theranostic for Gastrointestinal Cancer: Advances in Biomarker Discovery and Therapeutic Engineering

Small Methods, EarlyView.
This review explores the dual roles of exosomes in gastrointestinal (GI) cancers as diagnostic biomarkers and therapeutic agents. It highlights advancements in exosomal miRNAs, lncRNAs, circRNAs, and proteins for cancer detection and prognosis. The study also examines engineering strategies for exosome‐based drug delivery systems, their potential to ...
Mohit J. Mehta, Dongjun Shin, Hyun Sung Park, Jun Su An, Seong Il Lim, Hyun Jin Kim, Seungpyo Hong, Jiyoon Bu   +7 more
wiley   +1 more source

P-70 HEPATITIS B IMMUNITY AMONG CHRONIC RENAL DISEASE UNDER HEMODIALYSIS

Annals of Hepatology, 2023
Introduction and Objectives: Hepatitis B Virus (HBV) has been a cause of acute and chronic hepatitis with progression to cirrhosis and hepatocellular carcinoma.
Alanna Calheiros Santos, Juliana Gil Melgaço, Lucas Lima da Silva, Vanessa Duarte da Costa, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Julia Trece Marques, Giselle Prado do Nascimento, Vanessa Salete de Paula, Livia Melo Villar   +9 more
doaj  

Antibody responses to recombinant and plasma derived hepatitis B vaccines. [PDF]

, 1986
S E Brown, Carolynne Stanley, Colin R. Howard, Arie J. Zuckerman, Michael Steward   +4 more
openalex   +1 more source

Interdisciplinary Approach to Monkeypox Prevention: Integrating Nanobiosensors, Nanovaccines, Artificial Intelligence, Visual Arts, and Social Sciences

Small Structures, EarlyView.
This illustration depicts a comprehensive strategy against monkeypox, showcasing its transmission, symptoms, and prevention. Centralized around nanomaterials and biosensors, it integrates early screening, Internet of Things, vaccination, and community involvement through collaboration among healthcare workers, scientists, researchers, social groups ...
Vishal Chaudhary, Lucky Lucky, Harsh Sable, Nikhil Bhalla   +3 more
wiley   +1 more source

Renal function changes in chronic hepatitis B patients [PDF]

arXiv
The best way to treat chronic hepatitis B is with pegylated interferon alone or with oral antiviral drugs. There is limited research comparing the renal safety of entecavir and tenofovir when used with pegylated interferon. This study will compare changes in renal function in chronic hepatitis B patients treated with pegylated interferon and either ...
arxiv  

Impaired Immunogenicity of Hepatitis B Vaccine in Obese Persons

, 1986
D.J. Weber, W.A. Rutala, G.P. Samsa, S.E. Bradshaw, S.M. Lemon   +4 more
openalex   +3 more sources